相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Noncanonical Pathway for Regulation of CCL2 Expression by an mTORC1-FOXK1 Axis Promotes Recruitment of Tumor-Associated Macrophages
Hirokazu Nakatsumi et al.
CELL REPORTS (2017)
CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
Susanne Svensson et al.
CLINICAL CANCER RESEARCH (2015)
Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges
Maria Vela et al.
FRONTIERS IN IMMUNOLOGY (2015)
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
Irene Brana et al.
TARGETED ONCOLOGY (2015)
Inflammatory chemokines and metastasis-tracing the accessory
L. Borsig et al.
ONCOGENE (2014)
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Shahneen K. Sandhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Twist1 Induces CCL2 and Recruits Macrophages to Promote Angiogenesis
Janine M. Low-Marchelli et al.
CANCER RESEARCH (2013)
Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells
Teizo Yoshimura et al.
PLOS ONE (2013)
Epithelial-Mesenchymal Transition Induced by TNF-α Requires NF-κB-Mediated Transcriptional Upregulation of Twist1
Chia-Wei Li et al.
CANCER RESEARCH (2012)
CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms
Wei Bin Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes
Muhammad Riaz et al.
BREAST CANCER RESEARCH (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Transcription factors zeb1, twist and snai1 in breast carcinoma
Ylermi Soini et al.
BMC CANCER (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art
Irina Arnaoutova et al.
ANGIOGENESIS (2009)
Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
Qing-Quan Li et al.
CLINICAL CANCER RESEARCH (2009)
Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone
Xin Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Gali Soria et al.
CANCER LETTERS (2008)
CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation
Hernan Roca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor
Svetlana M. Stamatovic et al.
JOURNAL OF IMMUNOLOGY (2006)
CCL2 is a potent regulator of prostate cancer cell migration and proliferation
Robert D. Loberg et al.
NEOPLASIA (2006)
Different effects of estradiol and various antiestrogens on TNF-α-induced changes of biochemical markers for growth and invasion of human breast cancer cells
H Seeger et al.
LIFE SCIENCES (2006)
Mechanisms of disease: Estrogen carcinogenesis in breast cancer
JD Yager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A twist for survival and cancer progression
A Puisieux et al.
BRITISH JOURNAL OF CANCER (2006)
Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer
Y Mironchik et al.
CANCER RESEARCH (2005)
Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators
R Schiff et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
The Src kinase pathway promotes tamoxifen agonist action in ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor α promoter interaction and elevated steroid receptor coactivator 1 activity
YM Shah et al.
MOLECULAR ENDOCRINOLOGY (2005)
Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A
KH Hong et al.
BLOOD (2005)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance
R Schiff et al.
CLINICAL CANCER RESEARCH (2004)
Estrogen decreases chemokine levels in murine mammary tissue - Implications for the regulatory role of MIP-1 alpha and MCP-1/JE in mammary tumor formation
P Fanti et al.
ENDOCRINE (2003)
Chemokines: key players in cancer
M Arya et al.
CURRENT MEDICAL RESEARCH AND OPINION (2003)
CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
BT Fife et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists - Binding to a common chemokine receptor motif within the helical bundle
T Mirzadegan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
